Details about the nature of SMC processes and further information about SMC decisions are available from their website: http://www.scottishmedicines.org.uk The Scottish Medicines Consortium (SMC) assessed eculizumab for the management of Paroxysmal Nocturnal Haemoglobinuria (PNH) and advised NHS Scotland in November 2010 that it was not recommended for us...